BioCryst Pharmaceuticals Ownership | Who Owns BioCryst Pharmaceuticals?

Overview Forecast RevenueFinancials Chart Transcripts

BioCryst Pharmaceuticals Ownership Summary

BioCryst Pharmaceuticals is owned by 84.55% institutional investors, 1.15% insiders, and 14.30% retail investors. Blackrock is the largest institutional shareholder, holding 9.68% of BCRX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.15% of its assets in BioCryst Pharmaceuticals shares.

BCRX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	BioCryst Pharmaceuticals	84.55%	1.15%	14.30%
Sector	Healthcare Stocks	47.06%	8.01%	44.93%
Industry	Biotech Stocks	44.97%	7.82%	47.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	19.96M	9.68%	$123.33M
Vanguard group	18.77M	9.11%	$116.00M
Avoro capital advisors	12.57M	6.10%	$77.68M
State street	9.35M	4.54%	$57.76M
Kynam capital management, lp	8.83M	4.28%	$54.55M
Deerfield management company, l.p. (series c)	8.14M	3.95%	$50.28M
Alkeon capital management	7.10M	3.45%	$43.87M
Geode capital management	4.71M	2.29%	$29.12M
Caligan partners lp	4.60M	2.23%	$28.42M
Nuveen asset management	4.50M	2.18%	$27.78M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Rp management	3.85M	13.29%	$23.77M
Caligan partners lp	4.60M	6.64%	$28.42M
Kynam capital management, lp	8.83M	4.21%	$54.55M
Cutter capital management, lp	1.98M	3.68%	$12.21M
Oracle investment management	535.56K	3.09%	$3.31M
Dafna capital management	704.50K	1.04%	$4.35M
Avoro capital advisors	12.57M	1.03%	$77.68M
Deerfield management company, l.p. (series c)	8.14M	0.84%	$50.28M
Knott david m jr	314.31K	0.77%	$1.94M
Rice hall james & associates	2.08M	0.77%	$12.85M

Top Buyers

Holder	Shares	% Assets	Change
Caligan partners lp	4.60M	6.64%	3.84M
Deerfield management company, l.p. (series c)	8.14M	0.84%	3.14M
Alkeon capital management	7.10M	0.07%	3.00M
Kynam capital management, lp	8.83M	4.21%	2.30M
Nuveen asset management	4.50M	0.01%	1.88M

Top Sellers

Holder	Shares	% Assets	Change
Baker bros. advisors lp	75.78K	0.01%	-10.05M
State street	9.35M	0.00%	-8.13M
Braidwell lp	-	-	-3.38M
Citigroup	116.94K	0.00%	-2.16M
Point72 asset management	-	-	-1.62M

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	651.63K	0.00%	651.63K	$4.03M
Schonfeld strategic advisors	452.60K	0.02%	452.60K	$2.80M
Parkman healthcare partners	400.45K	0.33%	400.45K	$2.47M
Knott david m jr	314.31K	0.77%	314.31K	$1.94M
Td asset management	240.60K	0.00%	240.60K	$1.49M

Sold Out

Holder	Change
Tfo-tdc	-3.00
Financial gravity asset management	-8.00
Dinuzzo private wealth	-13.00
Newbridge financial services group	-15.00
Sjs investment consulting	-20.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	246	-1.99%	174,231,087	-2.64%	84	1.12%	125	7.76%	67	-4.29%
Mar 31, 2024	251	1.62%	178,960,740	1.28%	86	1.03%	116	3.57%	70	-10.26%
Dec 31, 2023	247	1.65%	176,694,388	1.14%	91	1.08%	112	-7.44%	78	34.48%
Sep 30, 2023	243	-2.41%	174,701,852	0.47%	92	1.09%	121	-1.63%	58	-1.69%
Jun 30, 2023	249	-3.49%	173,890,981	1.99%	91	1.12%	123	-6.82%	59	-18.06%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	6.52M	3.15%	-47.69K
iShares Russell 2000 ETF	5.29M	2.56%	-11.90K
SPDR® S&P Biotech ETF	4.09M	1.98%	45.28K
Vanguard Institutional Extnd Mkt Idx Tr	3.14M	1.52%	43.66K
Vanguard Small Cap Index	2.60M	1.25%	5.10K
CREF Stock R1	2.29M	1.11%	-
Fidelity Small Cap Index	2.11M	1.02%	-52.02K
iShares Russell 2000 Growth ETF	1.85M	0.89%	-
Fidelity Select Biotechnology	1.79M	0.86%	-
Vanguard Strategic Equity Inv	1.52M	0.73%	514.93K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jun 24, 2024	McKee Amy E	-	Sell	$54.35K
Jun 17, 2024	SANDERS MACHELLE	-	Sell	$28.13K
Jun 14, 2024	HEGGIE THERESA	-	Sell	$40.92K
May 30, 2024	LEVIN ALAN G	-	Buy	$50.00K
May 24, 2024	ASELAGE STEVE	-	Buy	$16.00K

Insider Transactions Trends

Date	Buy	Sell
2024 Q2	10	3
2024 Q1	-	-
2023 Q4	-	-
2023 Q3	-	-
2023 Q2	-	3

BCRX Ownership FAQ

Who Owns BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals shareholders are primarily institutional investors at 84.55%, followed by 1.15% insiders and 14.30% retail investors. The average institutional ownership in BioCryst Pharmaceuticals's industry, Biotech Stocks , is 44.97%, which BioCryst Pharmaceuticals exceeds.

Who owns the most shares of BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals’s largest shareholders are Blackrock (19.96M shares, 9.68%), Vanguard group (18.77M shares, 9.11%), and Avoro capital advisors (12.57M shares, 6.10%). Together, they hold 24.89% of BioCryst Pharmaceuticals’s total shares outstanding.

Does Blackrock own BioCryst Pharmaceuticals?

Yes, BlackRock owns 9.68% of BioCryst Pharmaceuticals, totaling 19.96M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 123.33M$. In the last quarter, BlackRock increased its holdings by 1.52M shares, a 8.22% change.

Who is BioCryst Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Rp management is BioCryst Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 13.29% of its assets in 3.85M BioCryst Pharmaceuticals shares, valued at 23.77M$.

Who is the top mutual fund holder of BioCryst Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of BioCryst Pharmaceuticals shares, with 3.15% of its total shares outstanding invested in 6.52M BioCryst Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools